Antipsychotic medication is associated with a constellation of metabolic abnormalities, including weight gain, an imbalance between glucose and insulin actions, and higher than normal lipid content. In particular, adolescent psychiatric patients are at increased risk for Type II Diabetes and cardiovascular disease when undergoing therapeutic treatment. Current analysis indicates that antipsychotic drugs have differing effects […]

The brain is a dynamically evolving structure. Rehabilitation interventions take advantage of its malleable properties that persist even after an injury from stroke. Various interventions are used in clinical practice at an attempt to restore normal activity in the brain. Non-invasive brain stimulation is a novel technique that may act as a facilitator of brain […]

  Decreased brain volume in frontal regions is a prominent feature of chronic schizophrenia and has been linked to impairments in psychological functioning and social disability. These impairments persist over the lifespan, with approximately 64% of individuals experiencing severe social disability 15 years after first being diagnosed with the illness. Finding ways to overcome barriers […]

22q11.2 deletion syndrome (22qDS) affects 1/4,000 newborns. People with this condition can have various medical problems, and approximately 30% develop psychiatric illness such as bipolar disorder or schizophrenia. A recent study explored parents’ experience of receiving a diagnosis of 22qDS for their child. Families identified an unmet need for information from their healthcare providers about […]